Free subscription to the Capitol Journal keeps you current on legislative and regulatory news.
States Target School Cell Phone Use At least four states have banned or severely restricted the use of smart phones in schools in the current legislative biennium. Florida became the first state to do...
Compounded Weight-Loss Drugs Creating Headaches for State Regulators With popular weight-loss drugs like Mounjaro, Ozempic and Wegovy in short supply, many doctors, pharmacies and other providers have...
In their seminal book on the American health care system, legendary investigative reporters Donald L. Barlett and James B. Steele offered a disturbing metaphor for the illogical nature of medical pricing...
PA Lawmakers Pass Bill Regulating PBMs The Pennsylvania legislature passed a bill ( HB 1993 ) aimed at increasing oversight of pharmacy benefit managers. If signed by Gov. Josh Shapiro (D), the measure...
In a sign of the times, states have begun pursuing bills that require disclosure of the use of artificial intelligence. In March, Utah Gov. Spencer Cox (R) signed SB 149 , making the state the first...
The U.S. Supreme Court will hear oral arguments in a case that could limit access to the abortion drug mifepristone on March 26. The FDA initially approved the drug for terminating pregnancies through seven weeks gestation in 2000 and extended that period to 10 weeks in 2016.
U.S. District Judge Matthew Joseph Kacsmaryk stayed FDA approval of the drug last April, but that decision was put on hold by the Supreme Court pending appeal. A three-judge panel of the 5th Circuit Court of Appeals ruled in August the drug could remain available under the prescription and dosage guidelines in effect prior to 2016, but that decision is on hold pending the ruling of the Supreme Court. (STATELINE)
A bill introduced in Arizona (SB 1511) would require doctors and health care institutions that provide gender-affirming care to also provide or pay for gender detransition procedures. The measure would also require insurers that cover gender-affirming care to cover detransition care. (NEWS FROM THE STATES, LEXISNEXIS STATE NET)
The governing board of the North Carolina State Health Plan voted last week to stop covering medications for weight loss, like the wildly popular drug Wegovy. The state spent $100 million on such drugs last year, 10% of the total amount it spent on prescription drugs. The state will continue to pay for versions of the drugs used to treat diabetes. (NEW YORK TIMES)
Legislation under consideration in Florida (SB 932/HB 773) would prohibit insurers from charging out-of-pocket costs for medically necessary diagnostic and supplemental breast exams. Over 22,000 Floridians were diagnosed with breast cancer last year, more than 3,000 of whom died from the disease, according to the Susan G. Komen organization, which attributed those figures in part to “exorbitant out-of-pocket costs associated with essential breast imaging procedures.” Close to a dozen states, including Georgia and Tennessee, have already passed measures similar to SB 932/HB 773. (FLORIDA POLITICS, SUSAN G KOMEN, LEXISNEXIS STATE NET)
—Compiled by SNCJ Managing Editor KOREY CLARK
Visit our webpage to connect with a LexisNexis® State Net® representative and learn how the State Net legislative and regulatory tracking service can help you identify, track, analyze and report on relevant legislative and regulatory developments.